2007
DOI: 10.1111/j.1745-7254.2006.00470.x
|View full text |Cite
|
Sign up to set email alerts
|

Endogenous histamine inhibits the development of morphine-induced conditioned place preference

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 32 publications
0
1
0
Order By: Relevance
“…In addition to this, preclinical evidence suggests that morphine-context associations rely on signaling from another neurotransmitter, hormonal, and neuromodulatory systems, including opioid, GABA, norepinephrine, serotonin, cannabinoid, nitric oxide, hypocretin/orexin, neuropeptide S, and cholecystokinin (Tzschentke, 1998 , 2007 ; Le Merrer et al, 2009 ; Li et al, 2009 ; Billa et al, 2010 ; Karimi et al, 2013 ; Ghavipanjeh et al, 2015 ; Loureiro et al, 2016 ; Zhang et al, 2016 ; Azizbeigi et al, 2019 ) as well as systems involved in immune function and inflammation (Ghahremani et al, 2006 ; Zhang et al, 2012 ; Chen et al, 2017 ). Additionally, evidence suggests that morphine-induced suppression of endogenous histamine is important for morphine CPP as bilateral lesions of the tuberomammillary nucleus, a brain region that expresses histamine-releasing neurons, potentiated the development of morphine CPP (Gong et al, 2007 ). Also, activation of scaffolding proteins such as receptor for activated protein kinase C 1 (RACK1) is necessary for morphine CPP (Wan et al, 2011 ; Liu et al, 2016 ).…”
Section: Neurobiology Of Drug-induced Cpp: Focus On Opioid Cppmentioning
confidence: 99%
“…In addition to this, preclinical evidence suggests that morphine-context associations rely on signaling from another neurotransmitter, hormonal, and neuromodulatory systems, including opioid, GABA, norepinephrine, serotonin, cannabinoid, nitric oxide, hypocretin/orexin, neuropeptide S, and cholecystokinin (Tzschentke, 1998 , 2007 ; Le Merrer et al, 2009 ; Li et al, 2009 ; Billa et al, 2010 ; Karimi et al, 2013 ; Ghavipanjeh et al, 2015 ; Loureiro et al, 2016 ; Zhang et al, 2016 ; Azizbeigi et al, 2019 ) as well as systems involved in immune function and inflammation (Ghahremani et al, 2006 ; Zhang et al, 2012 ; Chen et al, 2017 ). Additionally, evidence suggests that morphine-induced suppression of endogenous histamine is important for morphine CPP as bilateral lesions of the tuberomammillary nucleus, a brain region that expresses histamine-releasing neurons, potentiated the development of morphine CPP (Gong et al, 2007 ). Also, activation of scaffolding proteins such as receptor for activated protein kinase C 1 (RACK1) is necessary for morphine CPP (Wan et al, 2011 ; Liu et al, 2016 ).…”
Section: Neurobiology Of Drug-induced Cpp: Focus On Opioid Cppmentioning
confidence: 99%